Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2018 1
2019 4
2020 6
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

PubMed for Bookshelf ID: 5225256

15 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene-related peptide-targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug-drug interaction study.
Jakate A, Blumenfeld AM, Boinpally R, Butler M, Borbridge L, Contreras-De Lama J, McGeeney D, Periclou A, Lipton RB. Jakate A, et al. Headache. 2021 Apr;61(4):642-652. doi: 10.1111/head.14095. Epub 2021 Apr 5. Headache. 2021. PMID: 33818780 Free PMC article. Clinical Trial.
Drugs for Migraine.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Oct 5;62(1608):153-160. Med Lett Drugs Ther. 2020. PMID: 33434187 No abstract available.
Ubrogepant: First Approval.
Scott LJ. Scott LJ. Drugs. 2020 Feb;80(3):323-328. doi: 10.1007/s40265-020-01264-5. Drugs. 2020. PMID: 32020557 Free PMC article. Review.
Ubrogepant for the Treatment of Migraine.
Dodick DW, Lipton RB, Ailani J, Lu K, Finnegan M, Trugman JM, Szegedi A. Dodick DW, et al. N Engl J Med. 2019 Dec 5;381(23):2230-2241. doi: 10.1056/NEJMoa1813049. N Engl J Med. 2019. PMID: 31800988 Clinical Trial.
15 results